Synopsis Second-generation cryoballoon (CB2)- based PVI has exhibited encouraging clinical results in the treating paroxysmal (PAF) and persistent atrial fibrillation (PersAF). The present study aims to evaluate data on the safety, efficacy and long-term clinical success of CB2-based pulmonary vein isolation (PVI) in elderly patients (≥75 years of age). This week’s “ MED FACT ” discusses a clinical trial from International Journal of Cardiology, “E fficacy and safety of cryoballoon ablation in the elderly: A multicenter study ”. Authors: Heegar C.
H et.al. Key Takeaways CB2-based PVI in elderly patients (≥75 years) appears safe, associated with short procedure times and shows promising clinical success rates equal to patients of the younger population . Objective: To evaluate data on the safety, efficacy and long-term clinical success of CB2-based pulmonary vein isolation (PVI) in…
